Allopurinol alters the expression of cytokines and mediators of immune cells in the systemic 2 tissue by decreasing plasma urate. by Marku, Lundrim s
Graduate Theses, Dissertations, and Problem Reports 
2020 
Allopurinol alters the expression of cytokines and mediators of 
immune cells in the systemic 2 tissue by decreasing plasma 
urate. 
Lundrim s. Marku 
lsmarku@mix.wvu.edu 
Follow this and additional works at: https://researchrepository.wvu.edu/etd 
 Part of the Poultry or Avian Science Commons 
Recommended Citation 
Marku, Lundrim s., "Allopurinol alters the expression of cytokines and mediators of immune cells in the 
systemic 2 tissue by decreasing plasma urate." (2020). Graduate Theses, Dissertations, and Problem 
Reports. 7724. 
https://researchrepository.wvu.edu/etd/7724 
This Thesis is protected by copyright and/or related rights. It has been brought to you by the The Research 
Repository @ WVU with permission from the rights-holder(s). You are free to use this Thesis in any way that is 
permitted by the copyright and related rights legislation that applies to your use. For other uses you must obtain 
permission from the rights-holder(s) directly, unless additional rights are indicated by a Creative Commons license 
in the record and/ or on the work itself. This Thesis has been accepted for inclusion in WVU Graduate Theses, 
Dissertations, and Problem Reports collection by an authorized administrator of The Research Repository @ WVU. 
For more information, please contact researchrepository@mail.wvu.edu. 
Graduate Theses, Dissertations, and Problem Reports 
2020 
Allopurinol alters the expression of cytokines and mediators of 
immune cells in the systemic 2 tissue by decreasing plasma 
urate. 
Lundrim s. Marku 
Follow this and additional works at: https://researchrepository.wvu.edu/etd 
 Part of the Poultry or Avian Science Commons 
Allopurinol alters the expression of cytokines and mediators of immune cells in the systemic 
tissue by decreasing plasma urate. 
Lundrim Marku 
Thesis submitted to the Davis College of Agriculture, Natural Resources and Design at 
West Virginia University 
In partial Fulfillment of the requirements for the degree of Master of Science in Animal 
Physiology 
Hillar Klandorf, Ph.D, Chair
Ashok Bidwai, Ph.D, 
Jianbo Yao, Ph.D, 
Department of Animal and Nutritional Sciences, West Virginia University, 
Morgantown, West Virginia 
2020 
Keywords: Allopurinol, Chickens, Il-6, Tnf-alpha, brain inflammation. Gut inflammation. 
Copyright 2020: Lundrim Marku 
  
Abstract 
 
Allopurinol alters the expression of cytokines and mediators of immune cells in the systemic 
tissue by decreasing plasma urate. 
Lundrim Marku 
Diminished levels of urate have been linked to oxidative stress in birds and mammals. 
Urate, a major antioxidant that lowers reactive oxygen/nitrogen species (ROS/RNS), is thought 
to ameliorate the effects. The relationship between reduced urate, the immune system and the 
pathogenesis of the intestine, the liver or the brain has not been well characterized in avians. 
Moreover, recent studies have proposed that an increased permeability in the intestine due to 
some insult can induce inflammation in peripheral organs such as the brain. Allopurinol, a 
relatively toxic purine analogue that serves as a xanthine oxidase inhibitor, reduces urate levels 
which can subsequently induce an inflammation state in the intestine. For this study, White 
Leghorn Chickens (n=44) were divided into 11 groups, which constituted of six control groups 
and five allopurinol treatments fed at 15 mg/kg body weight. The dose of allopurinol was 
increased 5 mg/kg body weight each week for 12 weeks. Blood samples were obtained by from 
the brachial vein of the wing. Liver panel blood chemistries were performed to characterize the 
inflammations state. At the end of the study, tissues were removed after cervical dislocation and 
placed in liquid nitrogen. Expression levels of TNF-α, IL-6, FASLG and COX-2 were 
subsequently investigated in the intestines, liver and midbrain. The results showed that urate was 
reduced in all treatment groups regardless of time (p < 0.05), treatment groups exhibited reduced 
amounts of bile acids throughout time (p < 0.05) and female treatment groups exhibited 
increased amounts of LDH and AST from week 2 to the end of the experiment (p < 0.05). The 
effect of allopurinol on the intestines of females showed that expression of IL-6, COX-2, TNF-α 
expression increased from every other group by 185.93, 211.74 and 107.52 times respectively (p 
< 0.05).  TNF-α expression in the liver decreased in both females and males by 3 and 2-fold 
respectively (p < 0.05). FASLG expression in the liver decreased 2-fold in both male and 
females respectively (p < 0.05). The effect of allopurinol on the midbrain of females showed that 
IL-6 expression decreased by 0.061fold (?) (p < 0.05) whereas in males IL-6 expression 
increased by almost 2-fold (p < 0.05). COX-2 expression in the midbrain increased in females 
and males by 7 and 10 times (p < 0.05). The midbrain of treated females reveal that the 
inflammatory potential was reduced in the brain tissue of female chickens due to decreased IL-6 
expression. Females were found respond more intensely to allopurinol administration from an 
increase of intestinal permeability which could alter the laying quality and reproductive fitness. 
Lastly, an upregulation of IL-6 in males also induce inflammation and could be used to create a 
model of neuropathological disorders. 
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i. Introduction 
Urate is synthesized the liver, intestines and the vascular endothelium as a product of an 
exogenous pool of purines [1]. Urate can also be produced endogenously by damaged, dying or 
dead cells; where nucleic acids, adenine, and guanine, are degraded into urate to act as damage-
associated molecular patterns [1], [2]. This biomolecule conventionally generates concerns due 
to acute and chronic inflammatory arthritis, gout, and other metabolic diseases [1], [3]. However, 
it is also thought to have a dual role and serve by inducing a type 2 immune response [1], [2], 
[4]. The inhibition of urate production can elucidate the protective potential by observing how 
lowered urate concentrations alter immunological function in several organs [5], [6]. Several 
studies have indicated how the intestinal environment can exert profound effects on the liver and 
central nervous system through the regulation of the microbiota and the intestinal barrier 
function [7]. This gut-brain connection is becoming a model of immune activity with a 
fundamental contribution towards neurodegenerative disorders [7]. These studies indicate that 
inflammation in the intestine appears to be particularly relevant in the disease pathogenesis. 
Studies have shown that urate serves as a potent scavenger of singlet oxygen, peroxyl 
radicals and hydroxyl radicals [6]. Elevated urate concentrations in the circulation helps to 
protect cells by scavenging these free radicals which then prolongs the organism’s life [6], [8]. 
Living systems have adapted to regulate free radicals by developing pathways to inactivate these 
reactive species such as oxygen and nitrogen, which induce tissue injury [6], [9]. Allopurinol, a 
toxic purine analog, serves as a xanthine oxidase inhibitor which reduces urate concentrations; 
which can induce a type I inflammation state in the intestine and the brain of birds [3]. Changes 
in the compositions of the bacterial populations in the intestines have also been widely associated 
with an array of conditions that can cause neurological and developmental disorders such as 
  
multiple sclerosis, autism, depression, schizophrenia, and Parkinson’s disease [4], [7]. 
Shifts in intestinal microbiota can alter levels of growth factors and signaling proteins in 
the brain, which contributes to functional changes in the remodeling and inflammation?[5]. 
Among the roles for gut bacteria are the conversion of primary bile acids produced by the liver to 
secondary bile acids which then are absorbed through the intestinal epithelium [7]. Moreover, 
bile acids can also act as potent signaling molecules that regulate a variety of processes related to 
both the nervous and immune systems. A detailed look into the effects of allopurinol on the early 
recognition and effector response by the immune system in the intestines could elucidate how 
these responses affect the liver and brain [4], [7]. Metabolites generated from intestinal microbes 
such as those described here have also been reported to alter host gene expression in the brain, 
providing ways for the microbiota to influence the activity of the CNS [4], [7]. Thus, the 
administration of allopurinol can evoke strong type 1 immune reactions via IL-6 by altering the 
intestinal environment and induce effects that ultimately alter CNS function.  
The Immune System and The Urate Paradox 
A vast amount literature shows an elevated level of urate is strongly associated with 
inflammatory diseases such as hypertension, cardiovascular and cerebrovascular events [2], [3], 
[10]. While urate does account for over half of the free radical scavenging activity in blood [8], it 
can also be thought to combat the oxidative stress implicated in several neurodegenerative 
diseases. Antioxidant activities of urate can quench superoxide and singlet oxygen and protecting 
oxidation of vitamin C through the chelation of iron [6], [11]. These qualities make urate an 
attractive CNS antioxidant because neurons are remarkably susceptible to oxidative stress. In 
multiple sclerosis, free radicals can contribute to the inflammation and demyelination of axons 
[10], [12]. Thus, preventing oxidative damage may delay onset and improve the prognosis of 
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CNS disorders [10]. The ratio of reactive species over antioxidants determine the shift from their 
advantageous function to detrimental effects [11]. The major source of these reactive species that 
become detrimental are dependent on cell type, duration of oxidant production, reactive species 
produced, and the localization of their source [6]. The oxidant-antioxidant paradox can be further 
investigated by the analyzing how decreased blood urate can alter various genes associated with 
inflammation [4], [6], [10]. 
Urate’s Systemic Effects 
Immune cells can engage in direct communication with these dying cells as well as with 
neurons. The extent of the functional impact of neuroimmune synapses is not known. However, 
activated immune cells can modulate neuronal activity by using neurotransmitters and cytokines 
[4]. Proinflammatory cytokines and activated immune cells in the circulation also access the 
brain when the blood brain barrier is compromised [2]. Systemic inflammation associated with 
increased BBB permeability can be considered a precursor to neurodegenerative diseases [13]. 
Extensive evidence has reported linking molecules associated with inflammatory conditions, 
which include cytokines, reactive oxygen species, matrix metalloproteases, and mediators of 
angiogenesis with blood brain barrier disruption [2], [13]. Additionally, a positive feedback loop 
involving IL-6 in conjunction with neuroimmune reflex circuits has been implicated in 
increasing permeability such that peripheral T cells gain access to the CNS [7]. Leaks in the 
blood brain barrier can significantly alter immune responses to CNS antigens and compromise 
CNS protection against potentially harmful substances [7], [13]. 
The systemic effects of intestinal inflammation may be further augmented by increases in 
intestinal permeability via some insult to the gut [7]. Acute tissue injury may occur with a severe 
infection generated by an intestinal pathogen, which causes temporary defects in the intestinal 
  
epithelial barrier [2]. These low-grade insults induce more selective increases in paracellular 
permeability through regulation of tight junctions. Intestinal microbes also regulate expression of 
barrier promoting tight junction proteins [7]. While many proinflammatory cytokines secreted by 
activated immune cells, which include TNF, IL-1β, and IL-6, allow for tight junctions to increase 
barrier permeability in order to facilitate recruitment of immune cells and other molecules [2], 
[14], [15], [16], [17], [18]. However, a side effect of this response permits microbes to leak from 
the intestine into the peritoneal cavity and from there into the blood, which then triggers a 
systemic proinflammatory immune responses [7]. 
Typically, the immune challenge is rapidly cleared, proinflammatory responses terminate, 
and gut barrier function is restored [7].  However, unique features of the intestine allow for 
persistent inflammation and barrier dysfunction [7]. Sustained permeability of the intestinal 
barrier can have harmful effects on numerous body systems. Many microbial components can 
trigger “leaky gut syndrome” and lead to conditions like Irritable bowel syndrome (IBS) and 
metabolic syndrome. Moreover, recent studies have implicated that intestinal permeability can be 
with linked with CNS dysfunction, which include Parkinson’s, Alzheimer’s, autism, 
schizophrenia, multiple sclerosis, depression, anxiety, and post-traumatic stress disorder [7], [7]. 
Proinflammatory responses in the brain can alter CNS function and CNS immune responses can 
have serious and enduring consequences. If inflammation becomes chronic, proinflammatory 
cytokines and oxidative stress that are linked to neuron death, and neuroinflammation should be 
investigated as a key factor in numerous neurodegenerative diseases. 
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ii. Materials and Methods 
All procedures and experiments were approved by West Virginia University’s Institution 
Animal Care and Use Committee 1708009034. 
Experimental Design 
Chickens were housed within pens and maintained under a twelve-hour light-dark cycle 
with temperature set at 27°C. One dose of allopurinol will be administered (15 mg/kg of body 
weight) as a feed additive to chickens.  The chickens were allowed a growth period of two to 
three weeks before the start of treatments.  On the third week of age, the chickens will be 
assigned at random into treatment groups, Control diet and Allopurinol in the diet.  The 
treatment period will be 12 weeks until euthanasia.  Three weeks after growth, chickens (n = 44) 
were divided into 11 groups and tagged with a leg band. The chickens were maintained on a 
starter diet before the experiment began. The leghorn chickens were started on their respective 
treatment’s allopurinol were purchased from Sigma-Aldrich (Saint Louis, MO, USA). Food and 
water were provided ad libitum. At 12 weeks of age the birds were killed by cervical dislocation 
and the intestines, liver and midbrain tissues were removed and stored in liquid nitrogen prior to 
analysis. 
 
Sampling procedure 
Blood samples were obtained from the brachial wing vein of 2 birds per pen at week two 
of treatment for twelve weeks. Each blood sample was placed in a heparinized tube and stored on 
ice. The blood samples were centrifuged at 2000rpm for 20 minutes at 4°C. Plasma samples were 
then transferred to micro-centrifuge tube and stored in a -80° C freezer pending analysis.  
  
Sample analysis 
Plasma uric acid (PUA) was measured using Infinity™ Uric Acid Liquid Stable Reagent 
assay from Thermo Scientific (Waltham, MA, USA). Liver Blood panel chemistries were 
performed with the help of Dr. Jesse Fallon at the Cheat Lake Veterinary Hospital. 
RNA Extraction, cDNA Synthesis and qPCR Total RNA  
The primers used in these experiments can be referred to Table 1.  Total RNA was 
isolated from tissues using the TRIZOL Reagent (Invitrogen, Carlsbad, CA). To quantify 
expression levels, equal amounts of cDNA were synthesized using the Advantage RT-for-PCR 
kit (Clontech, Mountain View, CA). GAPDH was amplified as an internal control. qPCR was 
performed using Power SYBR Green PCR Master Mix (Applied Biosystems). All qPCR was 
performed using SYBR Green, conducted at 50°C for 2 minutes, 95°C for 10 minutes, and then 
40 cycles of 95°C for 15 seconds and 60°C for 1 minutes. The specificity of the reaction was 
verified by melt curve analysis. qPCR was conducted at 95°C for 10 minutes, followed by 40 
cycles of 95°C for 15 seconds and 60°C for 1 minutes. The threshold crossing value was noted 
for each transcript and normalized to the internal control. The relative quantitation of each 
mRNA was performed using the comparative delta delta Ct method. Experiments were 
performed using an ABI Prism 7900 System (Applied Biosystems), and data processing was 
performed using ABI SDS v2.1 software (Applied Biosystems). 
Statistical Analysis 
The statistical program SAS (version 14.3; SAS Institute Inc., Cary, NC) was used to 
analyze the data. Both time and treatment effects were analyzed. Weeks were considered as a 
fixed effect whereas birds were treated as random effect.  A generalized linear model was used to 
study the treatment effect at week 12 of the study. Values are expressed as least square (LSM) ± 
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standard error (SE) unless stated otherwise. JMP and SAS software (JMP®, Version Pro 14.0, 
SAS Institute Inc., Cary, NC, Copyright ©2015; SAS®, Version 9.4, SAS Institute Inc., Cary, 
NC, Copyright ©2002-2012). Significance criterion alpha for all tests was set to 0.05. 
iii. Results 
Plasma Urate and Liver Panel 
The results showed that plasma urate was reduced in all treatment groups regardless of 
time (p < 0.05) (Figure 1K). Treatment groups exhibited reduced amounts of bile acids 
throughout the study period (p < 0.05) (Figure 1L) while female treated birds exhibited increased 
amounts of LDH and AST over time (p < 0.05) (Figure 1D and 1J).  
Intestines 
In female chicks, allopurinol increased IL-6, COX-2, TNF-α expression by 186, 212 and 
108 times respectively (p < 0.05) (Figure 2A-C) with the combination of sex and treatment found 
to be significant (p <0.05) (Figure 2A). Tukey HSD, teste done to determine if there is an honest 
significant difference of LSM differences revealed that IL-6 expression was increased in females 
that were fed the allopurinol treatment (p < 0.05).  
Liver 
The effect of allopurinol on TNF-α expression was decreased in both females and males 
by 3 and 2-fold compared to their respective control groups (p < 0.05) (Figure 3a). The effect of 
allopurinol on FASLG expression in the liver was decreased by 2 times in both male and females 
from their respective control groups (p < 0.05) (Figure 3b).  
Midbrain 
Allopurinol administration to female chickens decreased IL-6 expression from its 
  
respective control to a fold change of 0.061 (p < 0.05) (Figure 4a) with the combination of sex 
and treatment also found to be significant (p < 0.05). Allopurinol administration to male chickens 
increased IL-6 expression from the respective controls by 1.98 times (p < 0.05) (Figure 4a) with 
the combination of sex and treatment was found to be significant (p < 0.05). Tukey HSD of LSM 
differences revealed that females with the allopurinol treatment have statistically decreased from 
every other group. Males were also found to statistically decrease from every other group with 
the control groups of both sexes statistically similar to each other. Allopurinol increased COX-2 
expression in the midbrain in both females and males by 7 and 10-fold compared to their 
respective control groups (p < 0.05) (Figure 4b). 
Figure 1A. Albumin-to-Globulin Ratio. Total plasma protein concentrations in female 
treated chickens (n = 11) female treated chickens(n=11) at 2, 6, 12 wks of age; Male treated 
chickens (n = 11) at 2, 6, 12 wks of age; Control Females (n = 11) at 2, 6, 12 wks of age. Control 
Males (n = 11) at 2, 6, 12 wks of age. 
Figure 1B. Albumin Concentrations. Total albumin concentrations in g/dL. Female 
treated chickens (n = 11) female treated chickens(n=11) at 2, 6, 12 wks of age; Male treated 
chickens (n = 11) at 2, 6, 12 wks of age; Control Females (n = 11) at 2, 6, 12 wks of age. Control 
Males (n = 11) at 2, 6, 12 wks of age. 
Figure 1C. Alkaline Phosphatase. Alkaline phosphatase concentrations in IU/L. Female 
treated chickens (n = 11) female treated chickens(n=11) at 2, 6, 12 wks of age; Male treated 
chickens (n = 11) at 2, 6, 12 wks of age; Control Females (n = 11) at 2, 6, 12 wks of age. Control 
Males (n = 11) at 2, 6, 12 wks of age. 
Figure 1D. Aspartate Aminotransferase. Aspartate aminotransferase concentrations in 
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IU/L. Female treated chickens (n = 11) female treated chickens(n=11) at 2, 6, 12 wks of age; 
Male treated chickens (n = 11) at 2, 6, 12 wks of age; Control Females (n = 11) at 2, 6, 12 wks of 
age. Control Males (n = 11) at 2, 6, 12 wks of age. Female treated birds exhibited increased 
amounts of AST over time (p < 0.05).  
Figure 1E. Creatine Kinase. Creatine kinase concentrations in IU/L. Female treated 
chickens (n = 11) female treated chickens(n=11) at 2, 6, 12 wks of age; Male treated chickens 
(n = 11) at 2, 6, 12 wks of age; Control Females (n = 11) at 2, 6, 12 wks of age. Control Males 
(n = 11) at 2, 6, 12 wks of age. 
Figure 1F. Globulin. Globulin concentrations in g/dL. Female treated chickens (n = 11) 
female treated chickens(n=11) at 2, 6, 12 wks of age; Male treated chickens (n = 11) at 2, 6, 12 
wks of age; Control Females (n = 11) at 2, 6, 12 wks of age. Control Males (n = 11) at 2, 6, 12 
wks of age. 
Figure 1G. Phosphorus. Phosphorus concentrations in mg/dL. Female treated 
chickens (n = 11) female treated chickens(n=11) at 2, 6, 12 wks of age; Male treated chickens 
(n = 11) at 2, 6, 12 wks of age; Control Females (n = 11) at 2, 6, 12 wks of age. Control Males 
(n = 11) at 2, 6, 12 wks of age. 
Figure 1H. Blood Urea Nitrogen. BUN. Female treated chickens (n = 11) female treated 
chickens(n=11) at 2, 6, 12 wks of age; Male treated chickens (n = 11) at 2, 6, 12 wks of age; 
Control Females (n = 11) at 2, 6, 12 wks of age. Control Males (n = 11) at 2, 6, 12 wks of age. 
Figure 1I. Total Protein. Total protein concentrations in g/dL. Female treated chickens 
(n = 11) female treated chickens(n=11) at 2, 6, 12 wks of age; Male treated chickens (n = 11) at 
2, 6, 12 wks of age; Control Females (n = 11) at 2, 6, 12 wks of age. Control Males (n = 11) at 2, 
  
6, 12 wks of age. 
Figure 1J. Lactate Dehydrogenase. LDH concentrations in IU/L. Female treated 
chickens (n = 11) female treated chickens(n=11) at 2, 6, 12 wks of age; Male treated chickens 
(n = 11) at 2, 6, 12 wks of age; Control Females (n = 11) at 2, 6, 12 wks of age. Control Males 
(n = 11) at 2, 6, 12 wks of age. Female treated birds exhibited increased amounts of LDH over 
time (p < 0.05).  
Figure 1K. Urate. Urate concentrations in mg/dL. Female treated chickens (n = 11) 
female treated chickens(n=11) at 2, 6, 12 wks of age; Male treated chickens (n = 11) at 2, 6, 12 
wks of age; Control Females (n = 11) at 2, 6, 12 wks of age. Control Males (n = 11) at 2, 6, 12 
wks of age. Plasma urate was reduced in all treatment groups regardless of time (p < 0.05).  
Figure 1L. Bile Acids. Bile Acids concentrations in μmol/l. Female treated chickens 
(n = 11) female treated chickens(n=11) at 2, 6, 12 wks of age; Male treated chickens (n = 11) at 
2, 6, 12 wks of age; Control Females (n = 11) at 2, 6, 12 wks of age. Control Males (n = 11) at 2, 
6, 12 wks of age. Treatment groups exhibited reduced amounts of bile acids throughout time (p < 
0.05). 
qPCR 
Table 1. Oligonucleotide primers for qPCR 
Gene   Forward (5'-3') Reverse (5'-3') Annealing (°C) 
Accession 
Number 
*GAPDH Ggtggccatcaatgatccct Ccgttctcagccttgacagt 60 NC_006088.5 
TNF-alpha Gagatcctccctgcactgaa Cacatcccctttctggaaga 60 NC_006101.5 
FASLG Tgctggacctcgtttagctt Ctcatttcccactgccatct 60 NC_006093.5 
IL-6 Aatggtgggggtcatatcaa Agtcacgtttgatggcttcc 60 NC_006089.5 
OCLN Cgagttggatgagtcccagta Ggtgtcgaactcctgcttgta 60 NC_006115.5 
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COX-2 Tcctcatgttcctgagcatct Gctcctgtttcaagagctcac 60 NC_006095.5 
KRT18 Gaactactgggacaccatcca Atgcctcatacttcaccctga 60 NC_008465.4 
CRP Tcttctcctacgccaccaaa Acgcggaaggtgacgtattt 60 NC_006112.4 
 
 
Figure 2a. The effect of allopurinol on IL-6 expression in the intestines of allopurinol fed 
chickens and healthy controls. IL6 mRNA was normalized to that of GAPDH. Female treated 
chickens (n = 3); Male treated chickens (n = 3); Control Females (n = 3). Control Males (n = 3). 
The treated female group had an LSM=185.93 and SE=32.74. The F-ratio was 7.25 and the p-
value = 0.0376 using an ANOVA test. The combination of sex and treatment was found to be 
significant with females at t-Ratio 2.72 and p-value=0.0263. Tukey HSD of LSM differences 
show that females with the allopurinol treatment IL-6 expression are statistically different from 
every group. 
Figure 2b. The effect of allopurinol on COX-2 expression in the intestines of allopurinol fed 
chickens and healthy controls. COX-2 mRNA was normalized to that of GAPDH. Female 
treated chickens (n = 3); Male treated chickens (n = 3); Control Females (n = 3). Control Males 
(n = 3). The treated female group had an LSM=211.74 and SE=18.144. The F-ratio was 11.909 
and the p-value=0.0376 using an ANOVA test. The combination of sex and treatment was found 
to be significant with females at t-Ratio 4.31 and p-value=0.0191.  
Figure 2c. The effect of allopurinol on TNF-α expression in the intestines of allopurinol fed 
chickens and healthy controls. TNF-α mRNA was normalized to that of GAPDH. Female 
treated chickens (n = 3); Male treated chickens (n = 3); Control Females (n = 3). Control Males 
(n = 3). The treated female group had an LSM=211.74 and SE=18.144. The F-ratio was 4.58 and 
the p-value=0.0376 using an ANOVA test. The treatment was found to be significant at a t-Ratio 
  
2.68 and p-value=0.0281.  
Figure 3a. The effect of allopurinol on TNF-α expression in the liver of allopurinol fed 
chickens and healthy controls. TNF-α mRNA was normalized to that of GAPDH. Female 
treated chickens (n = 3); Male treated chickens (n = 3); Control Females (n = 3). Control Males 
(n = 3). TNF-α expression of treated groups was statistically different from the control groups. 
The F-ratio was 4.33 and the p-value=0.0432 using an ANOVA test. All groups were found to 
similar when analyzing with Tukey-HSD. 
Figure 3b. The effect of allopurinol on FASLG expression in the liver of allopurinol fed 
chickens and healthy controls. FASLG mRNA was normalized to that of GAPDH. Female 
treated chickens (n = 3); Male treated chickens (n = 3); Control Females (n = 3). Control Males 
(n = 3).  FASLG expression of treated groups was statistically different from the control groups. 
The treatment was found to be significant at a t-Ratio 5.10 and p-value=0.0476. All groups were 
found to similar when analyzing with Tukey-HSD. 
Figure 4a. The effect of allopurinol on IL-6 expression in the midbrain of allopurinol fed 
chickens and healthy controls. IL6 mRNA was normalized to that of GAPDH. Female treated 
chickens (n = 3); Male treated chickens (n = 3); Control Females (n = 3). Control Males (n = 3). 
The effect of allopurinol on female chickens on IL-6 expression is statistically different from 
every other group with an LSM=0.061 and SE=0.031.  The effect of allopurinol on male 
chickens on IL-6 expression is statistically different from every other group with an LSM=1.98 
and SE=0.0312. The control groups of IL-6 expression is statistically different from every other 
group with females and males respectively LSM=1.089 and LSM= 1.219 and SE=0.031. The F-
ratio was 6.392 and p-value=0.016 using an ANOVA test. The combination of sex and treatment 
was found to be significant with females at t-Ratio -2.87 and p-value=0.021. Tukey HSD of 
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LSM differences show that females with the allopurinol treatment IL-6 expression are 
statistically different from every other group. Males were also found to be statistically different 
from every other group; while the control groups were statistically different every other group. 
Figure 4b. The effect of allopurinol on COX-2 expression in the midbrain of allopurinol fed 
chickens and healthy controls. COX-2 mRNA was normalized to that of GAPDH. Female 
treated chickens (n = 3); Male treated chickens (n = 3); Control Females (n = 3). Control Males 
(n = 3). The effect of allopurinol on COX-2 expression is statistically different from the control 
regardless of sex. The treatment was found to be significant at a t-Ratio 2.34 and p-
value=0.0476. All groups were found to similar when analyzing with Tukey-HSD. 
iv. Discussion: 
Urate was found to be reduced in all treatment groups regardless of time (p < 0.05) 
indicating that the allopurinol treatment generated an inflammatory state [12]. Liver panels were 
analyzed to determine if allopurinol could induce toxicity by analyzing major biomarkers. 
Treatment groups of both male and females revealed reduced amounts of bile acids throughout 
the study (p < 0.05), which suggest an inflammation state in both the intestinal tract and liver [7]. 
Lower concentrations of bile acids reduce cholesterol solubility, which leads to microcrystal 
formation and subsequently the formation of gallstones [7]. Female treated groups exhibited 
increased amounts of LDH and AST over time (p < 0.05).  The high levels of LDH in the 
females suggests some form of tissue damage, which could develop into severe disease over 
time. In addition, the high AST levels also serves as a sign of liver damage and immune system 
dysfunction [19], [20]. It is also important to note that albumin and globulin ratios were not 
altered which indicates that kidney and liver condition is still viable and able to function. 
Alkaline phosphatase function was not compromised which indicates that the breakdown of 
  
proteins was not altered, and subsequent liver diseases or bone disorder were not prevalent. Heart 
condition was not found to induce failure as indicated by creatine kinases. Total protein was not 
found to be different which indicates rates of clearance and production were not altered. BUN 
was found to be unaltered which indicated the kidneys are functioning well. IN addition, 
phosphorus also monitors kidney function but also bone and liver disease. No changes were 
found in the preceding. 
Intestines 
The effect of allopurinol administration on the duodenal section of the small intestine was 
evaluated by examining the expression levels of IL-6, IL-8, FASLG, CCL5, OCLN, TJP1 and 
TNF-α. Allopurinol treatment increased the expression of IL-6, COX-2, TNF-α in females by 
186, 212 and 108-fold respectively. Intestinal epithelial cells (IECs) form a highly organized 
cellular system. Analysis of the intestines is important because the system is maintained in a 
dynamic steady state by proliferating and differentiating cells [2], [21]. The cells that originate 
from the crypts of Lieberkühn have multiple tasks that participate in digestion, absorption, and 
protection [21]. All IECs have been shown to actively defend the epithelial surface, and aid in 
the recruitment of immune cells by expressing and secreting pro-inflammatory cytokines and 
chemokines [7], [21]. The intestinal cross talk uses growth factors, cytokines, chemokines, and 
extracellular proteins between IECs and other cell types to maintain homeostasis [2], [7].  
Interleukin 6 exerts multiple functions in the body and serves as indicator of intestinal 
inflammation with pleiotropic functions including both a pro-inflammatory and a trophic factor 
[4], [14], [15], [22]. Within the intestine, IL-6 has been shown to prevent epithelial apoptosis 
during prolonged inflammation while inducing intraepithelial lymphocytes to undergo epithelial 
proliferation and wound repair at the site of an inflammatory injury [14], [15], [22]. The 186-fold 
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increase of IL-6 in the gut is suggestive of significant immune recruitment and trophic functions 
of IECs resulting from the initial insult generated from allopurinol administration. Additionally, 
a secondary response could occur to combat infection from microbiota in treated females. 
Females may have had a greater induced response due to synergism with to egg laying [23]. The 
previous study investigated how probiotics and agents that induce gut sustainability and the 
strengthen of the gut barrier would increase the capability, quality of the eggs and the overall 
health of females. Which could also warrant reproductive studies to determine the toxicology of 
allopurinol and how laying cycles alter reproductive hormones concentrations. An overactive 
immune system could be working to correct the initial insult and protect the offspring by over 
expressing IL-6 for wound recovery, cell proliferation and the introduction of lymphocytes [9], 
[7], [15], [22]. 
COX-2 converts arachidonate to prostaglandin H2 and is constitutively expressed in the 
endothelium, kidney, brain and cancers [23]. COX-2 is responsible for the production of 
inflammatory prostaglandins and the upregulation associated cell adhesion, resistance to 
apoptosis, and tumor angiogenesis [7], [21], [22]. The 212-fold increase of COX-2 in the 
intestines is thus suggestive of the upregulation of cell adhesion to prevent the blood barrier from 
deteriorating, especially in females in order to ensure reproductive success associated with egg 
lay. Lastly, TNF-α is regulator of both the immune response and inflammation. TNF- α is 
expressed by macrophages, T-cells and NK cells, which causes both inflammation and 
endothelial activation [7], [15], [21], [22]. The 108-fold increase from the intestines suggests 
recruitment of the lymphocytes listed above, resulting in inflammation and endothelial activation 
in order to remodel the deteriorating regions from the toxic effects of allopurinol [4]. Allopurinol 
as a chemical agent is shown to induce gut instability and the weaken of the gut barrier, alter the 
  
quality of the eggs and the overall fitness of females [23]. An overactive immune system is 
working to ameliorate these effects by inducing wound recovery. Which could also warrant 
reproductive studies to determine the toxicology of allopurinol on how of reproductive hormones 
are being alter in laying cycles concentrations [23]. 
Liver 
The effect of allopurinol administration on the liver was evaluated by examining 
expression levels of IL-6, FASLG, CCL5, CRP, KRT-18, OCLN, TJP1 and TNF-α. The liver is 
the target organ for many toxic chemicals and plays a central role in detoxification and 
elimination [17], [19], [24]. However, when chemical or biological compounds overload the 
livers’ functional capacity to clear the drug or infection, it begins to fail [14], [20], [24]. 
Allopurinol treatment decreased TNF-α expression in the liver in both females and males by 3 
and 2-fold compared to the respective control groups while FASLG expression decreased 2-fold 
in both male and females compared to their respective controls. The Fas receptor/ligand system 
is the most important apoptotic initiator in the liver [20]. Dysregulation of this pathway can 
contribute to abnormal cell proliferation, cell death and prevent the immune system from 
targeting cancer cells [20], [24]. The findings suggest that the treated groups did not have any 
decrease in hepatocyte homeostatic and mitogenic activity, which could have led to liver damage 
and other associated pathologies. However, the findings are counterintuitive to the results from 
the liver panel which suggested that the low levels of bile acids, increased LDH and AST 
indicated liver damage. Moreover, the expression of KRT18, a biomarker for cell damage 
analogous to CK in heart failure, was also not shown to have any significant changes [24].  
Midbrain  
The effect of allopurinol administration on the midbrain was evaluated by examining 
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expression levels of IL-6, FASLG, CCL5, OCLN, TJP1 and TNF-α. Interleukin-6 plays a critical 
role in the pathogenesis of inflammatory disorders and in the physiological homeostasis of neural 
tissue [7], [13], [25]. Profound neuropathological changes such as multiple sclerosis, Parkinson's 
and Alzheimer's disease are associated with increased IL-6 expression in brain [7], [13], [25]. 
Allopurinol administration to the egg laying female chickens decreased IL-6 expression 
compared to its respective controls to a fold change of 0.061 with the combination of sex and 
treatment found to be significant (P <0.05). These data suggest that allopurinol reduced both the 
remodeling potential and inflammation state in these birds [26]. However, allopurinol increased 
IL-6 expression in adult male chickens compared to their respective controls by 1.98 times with 
the combination of sex and treatment found to be significant (P<0.05), which suggests that males 
were more suspectable to developing inflammation when comparing both treatment groups [26]. 
The upregulation in IL-6 expression suggests the use of male treated chickens to investigate 
other neuropathological disorders [7]. However, additional experiments need to be conducted to 
determine if other inflammatory pathways are also being upregulated could mimic conditions 
such as multiple sclerosis, Parkinson's and Alzheimer's disease. 
COX-2 is an inducible and rapidly expressed gene that responds to growth factors, 
cytokines, and pro-inflammatory molecules [27], [28]. Since its discovery, COX-2 has been 
recognized as a major contributor to inflammatory reactions in peripheral tissues that can 
progress to several acute and chronic diseases [7], [27], [28]. However, in the central nervous 
system, COX-2 is expressed under normal conditions and contributes to fundamental brain 
functions, such as synaptic activity, memory consolidation, and functional hyperemia [27], [29]. 
The gene is thus tightly regulated, as it is triggered and sustained by the activation of microglia 
[27], [29]. Allopurinol increased COX-2 expression in the midbrain both females and males by 7 
  
and 10-fold respectively, which suggests that that both treated groups are involved in extensive 
neuroinflammation and remodeling due low urate levels [29]. 
v. Conclusion: 
The reduced levels of urate in avians that have been traditionally linked to oxidative 
stress, now purport investigations on the mechanisms by which urate interacts with systemic 
organs. Results from the present study suggest that the inflammatory pathways in the intestines 
of female’s chickens respond more intensely to allopurinol administration than males. 
Interestingly, allopurinol treatment results in an increase in intestinal permeability due to insult 
from the drug, which increases the expression of IL-6. Moreover, expression levels of IL-6 in the 
brain of males suggest that inflammation was induced in the midbrain. The function of 
neurological remodeling and inflammation associated with it to be increased in both sexes with 
the upregulation of COX-2 occurring in both sexes. Allopurinol was suggested to induce cellular 
remodeling of the intestines and generate an inflammation state in due to the upregulation of IL-
6, COX-2 and TNF-α. Which could also warrant reproductive studies to determine the 
toxicology of allopurinol on how of reproductive hormones are being alter in laying cycles 
concentrations. Results from the liver panel also suggested an inflammatory state as reduced 
amounts of bile acids and urate and increased amounts of LDH and AST were measured in 
females. However, TNF-α and FASLG expression in the liver were decreased in both females 
and males, which indicates that the inflammation may not have been severe. The midbrain of 
allopurinol treated females revealed that IL-6 expression decreased, which suggests that 
allopurinol reduces the inflammatory potential in the brain tissue of female chickens. However, 
an upregulation in males could indicate that allopurinol induces an increase in IL-6 which could 
be used to create a model of neuropathological disorders. The increased expression COX-2 also 
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bolsters the idea that neuromodulation is upregulated due to treatment. Additional experiments 
must be conducted in males to determine if other inflammatory pathways are being upregulated 
that could possibly mimic the conditions associated with the development of multiple sclerosis, 
Parkinson's and Alzheimer's disease. 
 Future experiments should involve a redesign of the experiment model by four separate 
groups: control males, control females, treated males and treated females each with their own 
feed to strengthen the power of these findings. Another facet that could be improved upon is 
preforming weekly or biweekly bleeds of all chickens as well as collection of tissues. With these 
bleeds, additional biomarkers could be measured with liver panels and evaluating genes that are 
involved with liver toxicity, inflammation and regulatory pathways. Additional proinflammatory 
proteins that should be investigated include IL-1B, IL-11 and IL-8, whereas regulatory pathways 
can be further characterized by investigating IL-4, IL-6, IL-10, IL-11, and IL-13. In addition to 
evaluating mRNA expression levels of these biomarkers, protein levels could be investigated 
with ELISAs. Lastly, additional biomarkers associated with neurological disorders should be 
measured to determine the effect of low urate on neurological inflammation. 
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Intestine 
 
Figure 2a. Relative expression levels of IL-6 in the intestines. 
The effect of allopurinol on female chickens for IL-6 expression is statistically 
increased from every other group by 185.93 times.  
  
Figure 2b. Relative expression levels of COX-2 in the intestines. 
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The effect of allopurinol on female chickens for COX-2 expression is statistically 
increased from every other group by 211.74 times.  
 
 
Figure 2c. Relative expression levels of TNF-α in the intestines. 
The effect of allopurinol on female chickens for TNF-α expression is statistically 
increased from every other group by 107.52 times. 
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Liver 
 
Figure 3a. Relative expression levels of TNF-α in the liver. 
The effect of allopurinol on TNF-α expression has statistically decreased in both 
female and male by 3 and 2 times from the control groups respectively.  
 
Figure 3b. Relative expression levels of FASLG in the liver. 
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The effect of allopurinol on FASLG expression has statistically decreased by 2 times 
in both male and females from the control group respectively. 
Midbrain 
 
Figure 4a. Relative expression levels of IL-6 in the midbrain. The effect of 
allopurinol on female chickens on IL-6 expression has statistically decreased from its 
respective control with an LSM=0.061 and SE=0.0312.  The effect of allopurinol on male 
chickens on IL-6 expression has statistically increased from its respective control group 
LSM=1.98 and SE=0.0312.  
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Figure 4b. Relative expression levels of COX-2 in the midbrain. 
The effect of allopurinol on COX-2 expression has statistically increased in females 
and males by 7 and 10 times from the control group respectively.  
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